English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

We investigated the expression of TIMP1, TIMP2, SPARC, VCAN, and CLEC3B genes, encoded matricellular proteins with pleiotropic functions, and glucose intolerance in obese male subjects with normal and impaired glucose tolerance. The purpose of this study was to examine the association between the gene expressions and glucose intolerance in obesity. The results indicate that obesity leads to significant increase of TIMP1, TIMP2, E2F1 and CLEC3B gene expressions in subcutaneous adipose tissue, especially TIMP2 gene. However, more significant increase of the expression of TIMP1 and TIMP2 was found in adipose tissue of obese patients with glucose intolerance. No significant changes were found in the expression of VCAN and SPARC genes in adipose tissue of obese subjects with normal glucose tolerance but increased in the group of obese subjects with glucose intolerance. At the same time, the E2F1 and CLEC3B gene expressions were decreased in adipose tissue of obese patients with glucose intolerance. Results of this study provide evidence that changes in the expression of genes encoded TIMP1, TIMP2, VCAN, SPARC, E2F1 and CLEC3B in subcutaneous adipose tissue of obese individuals associate with glucose intolerance.

cellbio

The Expression of &amp;lt;i&amp;gt;TIMP&amp;lt;/i&amp;gt;1, &amp;lt;i&amp;gt;TIMP&amp;lt;/i&amp;gt;2, &amp;lt;i&amp;gt;VCAN&amp;lt;/i&amp;gt;, &amp;lt;i&amp;gt;SPARC&amp;lt;/i&amp;gt;, &amp;lt;i&amp;gt;CLEC&amp;lt;/i&amp;gt;3&amp;lt;i&amp;gt;B&amp;lt;/i&amp;gt; and &amp;lt;i&amp;gt;E&amp;lt;/i&amp;gt;2&amp;lt;i&amp;gt;F&amp;lt;/i&amp;gt;1 in Subcutaneous Adipose Tissue of Obese Males and Glucose Intolerance